Business Wire

PIXITMEDIA

Share
pixitmedia, a Kalray Subsidiary, Joins AWS ISV Accelerate Program, Strengthening Its Position within the Media & Entertainment Industry

pixitmedia1 , a Kalray company, has announced today that it has been accepted into the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program , a co-sell program for AWS Partners who provide software solutions that run on or integrate with AWS. The program helps partners drive new business and accelerate sales cycles by connecting the participating ISVs with the AWS Sales organization.

pixitmedia’s acceptance into the AWS ISV Accelerate program enables the company to meet customer needs through collaboration with the AWS Sales organization. Close collaboration with the AWS Sales team enables pixitmedia to provide better outcomes to AWS customers, as AWS ISV Accelerate Partners and the AWS team work together.

pixitmedia is a trusted solution provider in the Media & Entertainment industry specializing in storage and data management allowing customers to accelerate their journey into the Cloud. The software defined solutions of pixstor and ngenea allow customers to collaborate on a global scale, integrating seamlessly for productions in the cloud. Pixitmedia is a Kalray company (Euronext Growth Paris: ALKAL), a global leader in DPU processors and high-performance computing technologies for data-intensive applications.

The acceptance into the program cements pixitmedia’s position as a valued global AWS partner and industry enabler of cloud-enabled production workflows. pixstor offers AWS customers an agile storage environment that guarantees adaptability and performance, coupled with the power of pixitmedia’s ngenea, that quickly and securely transports data to and from globally distributed cloud, object storage, and traditional NAS files. Together pixitmedia and AWS are a formidable force when servicing creative processes in the cloud.

Being selected by Amazon Web Services as a member of the ISV Accelerate Program is a strong recognition of our current momentum within the Media & Entertainment Industry. As our products are selected more and more by leading media companies worldwide, we are committed to providing our joint AWS customers ease of use, greater collaboration and seamless workflows. Together we allow customers to realize their creative vision .” Eric Baissus, President and CEO of Kalray.

’We are delighted to be part of the ISV Accelerate Program with AWS, to be validated by AWS and recognized as a top partner is testament to the dedication of our teams. We are looking forward to driving more growth and new business whilst delivering the best value and choice for our customers .’’ Paul Cameron, Senior Vice President of Sales, Kalray.

pixitmedia has been working closely with AWS teams across the business. Since joining the APN marketplace in 2021 the company has deployed multiple solutions for joint customers, such as Taylor James, a tag company, Brown Bag Films and Passion Pictures, alongside global Media production and distribution companies. pixitmedia offers solutions for various media workflow challenges such as Efficient Burst Render, Hybrid Workflows, Automated Back-Up and Archive, Cloud Migration, Cloud Studio, On-Demand, Disaster Recovery, True Global Collaboration and Bottomless Storage.

In the past six months, not only has pixitmedia been nominated for the ISV Accelerate Program, but it also qualified for AWS ISV Workload Migration Program (WMP), which helps customers to migrate Independent Storage Vendor (ISV) workloads to Amazon Web Services (AWS) to achieve their business goals and accelerate their cloud journey. Work Migration Program helps pixitmedia to simplify cloud data migration, access, and collaborate processes, thus delivering more efficient and profitable ways of working for its customers. All migrations are delivered through pixitmedia’s trusted partner network and services consultants.

Ben Leaver, EVP Business Development and Co-Founder of pixitmedia , explains:
Cloud workflows are woven into the DNA of organizations and have become an engine for productivity, and a driver of digital transformation, particularly in Media & Entertainment Production. The AWS ISV Workload Migration Program allows us to offer organizations the opportunity to extend and lean further into cloud productivity and capitalize on those benefits to remain agile and stay competitive .”

A POWERFULLY SUCCESSFUL FUTURE
This news also follows pixitmedia’s recent certification as an AWS Technology Partner in the AWS Partner Network, the global community of consulting and technology partners who leverage AWS to build trusted solutions and services for customers. This further cements the company’s position as a valued global AWS partner and industry enabler of cloud-enabled production workflows. To learn more about pixitmedia and AWS solutions and the requirements and benefits of the AWS ISV Accelerate Program contact marketing@pixitmedia.com .

ABOUT PIXITMEDIA
pixitmedia is a Kalray company (Euronext, ALKAL), a leading provider in the new generation of processors and acceleration cards specialized in Intelligent Data Processing from cloud to Edge. pixitmedia and Kalray share a common vision and a complementary value proposition in both software and hardware to address today’s and tomorrow data-intensive world with solutions for a more intelligent, effective, energy-wise and user-friendly data-driven world.

pixitmedia facilitates seamless collaboration to enable the power of ideas. Our award winning purpose-built, software-defined storage and data solutions simplify the flow of data to connect an increasingly complex world. Our aim is to deliver beyond expectations throughout all areas of our operation. We devise optimized solutions that give customers both choice and freedom, our restless innovation constantly pushes boundaries and the unrivalled care and knowledge of our team ensure optimum performance and value. Customer success is at the heart of our business, we have technical specialists and a unique, dedicated lab facility to guarantee the effectiveness of our solutions. For more information, please visit https://pixitmedia.com or contact us: marketing@pixitmedia.com

ABOUT KALRAY
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, a leading provider of a new class of processors, specialized in Intelligent Data Processing from Cloud to Edge. Kalray’s team have created and developed its leading-edge technology and products to help its clients maximize the market possibilities presented by a world dominated by massive, disparate and pervasive data.

Thanks to Kalray’s patented manycore architecture, Kalray’s MPPA® Intelligent Data Processors are natively capable of managing multiple workloads with no bottlenecks to enable smarter, more efficient and energy-wise data-intensive applications. Kalray's offering includes processors, acceleration cards with associated software environment and appliances, allowing its customers to design the best solutions in fast growing sectors such as modern data centers, 5G, AI and Edge Computing, autonomous vehicles and others.

Founded in 2008 as a spin-off of CEA French lab, with investors such as Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance, Kalray is dedicated through technology, expertise and passion to offer more: More for a smart world, more for the planet, more for customers and developers. www.kalrayinc.com

1 pixitmedia is the dedicated branch for Media & Entertainment markets of Arcapix Holdings Ltd, acquired by Kalray. See press release on March 3, 2022 .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics8.1.2026 07:30:00 CET | Press release

FDA IND clearance enabling the worldwide expansion of the INFLAM MOTION Phase 2a trial, involving major U.S. sites Advancing the first clinical proof of concept in OA with a first-in-class intra-articular GLP-1 agonist A holistic clinical strategy design establishing the foundation for a future accelerated approval pathway 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for 4P004, enabling the expansion of the Phase 2a INFLAM MOTION clinical trial into the United States (US). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107798042/en/ 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. F

Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo®in France, Denmark, Iceland, Sweden, Finland and Norway8.1.2026 07:30:00 CET | Press release

The agreement builds on Organon’s cardiovascular disease portfolio, leveraging expertise to expand access to new treatments for patients with dyslipidemia, especially statin-intolerant patients.This collaboration addresses a critical gap in care that disproportionately affects women, who are at a 47% higher risk of developing statin intolerance compared to men.i Organon today announced that it has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway. Nilemdo® is a new, first-in-class drug indicated for patients with high cholesterol and cardiovascular disease risk. It provides an alternative treatment for patients that cannot be treated effectively with statins.ii “This collaboration combines Organon’s commercial agility with Daiichi Sankyo’s expertise in cardiovascular innovation to bring Nilemdo® to patients in France, Denmark, Iceland, Sweden, Finland and Norway,” says Thibault Crosnie

Prodapt Earns ISO 42001 Certification, the New Global Benchmark for Responsible Enterprise AI8.1.2026 07:00:00 CET | Press release

Prodapt today announced that it has been awarded the ISO 42001 certification, the world’s first and the only global standard for AI Management Systems (AIMS). Marking a significant milestone in its journey, Prodapt is setting a higher benchmark to deliver secure, ethical, and scalable AI for global enterprises. ISO 42001 lays a rigorous framework for governing AI across strategy, technology, and operations. The certification, awarded by an independent accredited body, validates Prodapt’s enterprise-grade AI management framework, including executive-led oversight, strong technology foundations, and disciplined operational processes. These measures ensure AI systems are responsibly designed, deployed, monitored, and evolved throughout their lifecycle. The evaluation emphasizes risk management, ethical AI practices, transparency, and scalability, confirming Prodapt’s ability to proactively identify and mitigate risks while ensuring accountability in AI-driven outcomes. Human-in-the-loop c

Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference8.1.2026 07:00:00 CET | Press release

Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare Conference on Thursday, January 15. The company’s presentation will begin at 9:30 am PT/12:30 am ET/6:30 am CET. The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann-Pick type C disease ((NPC). Two pivotal Phase 3 studies investigating nizubaglustat in GM1/GM2 gangliosidoses and NPC are currently enrolling, with data expected in 2027. The studies build on positive data from a robust clinical program including the Phase 2 RAINBOW study and the PRONTO natural history study. The Phase 3 studies are financed following the company’s successful completion of €132 million series B round completed in 1H 2025. About nizubaglust

Zilch to Acquire Fjord Bank to Kickstart European Expansion8.1.2026 01:40:00 CET | Press release

Acquisition will provide Zilch, the UK and EMEA’s fastest-growing fintech unicorn, with a European banking licence as it eyes international rollout Zilch, the consumer payments platform powering the future of commerce, today announces it has signed an agreement to acquire AB Fjord Bank, a Lithuania-based bank with approx. $120M in total assets that is authorised and regulated by the Bank of Lithuania and the European Central Bank. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107714872/en/ Zilch to Acquire Fjord Bank to Kickstart European Expansion The acquisition will represent a major strategic milestone for Zilch, providing a European banking licence that will enable the accelerated rollout of its offering across Europe. Zilch will purchase 100% of Fjord Bank and will establish Lithuania as its European headquarters as a consequence of the transaction, using Vilnius as its operational and regulatory platform for expan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye